l9n/ Oregon

2019 Regular Session

House Bill 2696

Establishes Drug Cost Review Commission to determine excess costs for certain prescription drugs and to set maximum payment rates for certain prescription drugs sold in this state by suppliers other than manufacturers.

Did not become law. It stopped in the House of Representatives's Health Care Committee on June 30, 2019. The 2019 session has ended.

What it does

The synopsis the Legislative Assembly published with the bill.

Establishes Drug Cost Review Commission to determine excess costs for certain prescription drugs and to set maximum payment rates for certain prescription drugs sold in this state by suppliers other than manufacturers. Requires investigation by Attorney General of complaints of payment rates that exceed payment rates established by commission. Adds new provisions considered unlawful trade practices.

Sponsors

Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.

In the House of Representatives

1 co-sponsor

Tawna Sanchez

Its course

January 14 to June 30, 2019, on one scale. In the top row each mark is a day something happened; taller marks are busier days.

Each committee stop sits inside its chamber.

Every action4 actions on 4 days

In the House of RepresentativesJan 14 to Jun 30 · stopped167 days

Waiting for a committeeJan 14 to Jan 162 days

Health CareJan 16 to Jun 30 · stopped165 days

Text

Each version as the Legislative Assembly printed it.

l9n doesn't hold this bill's text yet.

What happened

In l9n's words, one line for each step. Every action as the Legislative Assembly published it is below.

In the House of Representatives Jan 14 – Jun 30

  1. Jan 14Introduced
  2. Jan 16Sent to Health Care
  3. May 30Heard in Health Care
  4. Jun 30Died when the session ended
All 4 actions, as published
  1. Jan 14First reading. Referred to Speaker's desk.House of Representatives
  2. Jan 16Referred to Health Care with subsequent referral to Ways and Means.House of Representatives
  3. May 30Informational Meeting held.House of Representatives
  4. Jun 30In committee upon adjournment.House of Representatives